This combination of peptides repairs skin and reduces fine lines and wrinkles. It is also used for hair growth in clients. The Argireline and Leuphasyl combination add in botox like effects with the ability to reduce fine lines and wrinkles by ~30% in 30 days (Lim). GHK-cu is a great peptide not only for skin but also for it’s ability to help with wound healing. It is used often topically for the face or other areas to reduce wrinkles. It can help with hyperpigmentation or UV radiation damage. Though, it is hypothesized that CHK-cu can also help with age-related cognitive decline when used as an injectable (Pickart).

Helps with:
-       Improves elasticity
-       Tightens skin in clinical studies
-       Improves skin density and firmness
-       Improves photo-damage and hyperpigmentation
-       Reduces fine lines and wrinkles
-       Improve skin clarity
-       Increases keratinocyte production
-       Reverses thinning skin
-       Repairs skin
-       Helps smooth rough skin
-       Protects skin from the harmful UV radation
-       Increases hair growth, thickness and enlarges hair follicle size
-       Anti-oxidant and anti-inflammatory
-       Possibly age-associated neurodegeneration and cognitive decline

1.     Lim, S. H., Sun,Y., Madanagopal, T. T., Rosa, V., & Kang, L. (2018). Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep, 8: 1596. DOI: 10.1038/s41598-017-18454-z
2.     Pickart L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci, 19(7), 1987. DOI: 10.3390/ijms19071987
3.     Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2012). The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health. Oxid Med Cell Longev, 2012, 324832. DOI: 10.1155/2012/324832
4.     Wang, Y., Wang, M., Xiao, S., Pan, P., Li, P., & Huo, J. (2013). The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled Study. Am J Clin Dermatol, 14(2), 147-53. DOI: 10.1007/s40257-013-0009-9